FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1532055560> ?p ?o ?g. }

• W1532055560 abstract "=Theoretically, autologous serum eye drops (AS) have a potential advantage over traditional therapies based on the assumption that ASserve not only as a lacrimal substitute to provide lubrication, but also contain other biochemical components mimicking natural tears more closely. The application of AS in dry eye treatment has gained popularity as a second-line therapy in the treatment of dry eye.Published studies on the subject indicate that autologous serum could be an effective treatment for dry eye.To evaluate the efficacy and safety of AS compared to artificial tears for treating dry eye.We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 3),Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE,(January 1950 to April 2013), EMBASE (January 1980 to April 2013), Latin American and Caribbean Literature on Health Sciences(LILACS) (January 1982 to April 2013), themetaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov(www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We also searched the Science Citation Index Expanded database (September 2013) and reference lists of included studies. We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 15 April 2013.We included randomized controlled trials (RCTs) in which AS was compared to artificial tears in the treatment of dry eye in adults.Two review authors independently screened all titles and abstracts and assessed full-text articles of potentially eligible trials. Two review authors extracted data and assessed the methodological quality and characteristics of the included trials.We contacted investigators for missing data. For both primary and secondary outcomes, we reported mean differences with corresponding 95% confidence intervals(CIs) for continuous outcomes.We identified four eligible RCTs in which AS was compared with artificial tear treatment or saline in individuals (n = 72 participants)with dry eye of various etiologies (Sjögren’s syndrome-related dry eye, non-Sjögren’s syndrome dry eye and postoperative dry eye induced by laser-assisted in situ keratomileusis (LASIK)). The quality of the evidence provided by these trials was variable. A majority of the risk of bias domains were judged to have an unclear risk of bias in two trials owing to insufficient reporting of trial characteristics.One trial was considered to have a low risk of bias for most domains while another was considered to have a high risk of bias for most domains. Incomplete outcome reporting and heterogeneity in the participant populations and follow-up periods prevented the inclusion of these trials in a summary meta-analysis. For the primary outcome, improvement in participant-reported symptoms at one month, one trial (12 participants) showed no difference in participant-reported symptoms between 20% AS and artificial tears. Based on the results of two trials in 32 participants, 20% AS may provide some improvement in participant-reported symptoms compared to traditional artificial tears after two weeks of treatment. One trial also showed positive results with a mean difference in tear breakup time (TBUT) of 2.00 seconds (95% CI 0.99 to 3.01 seconds) between 20% AS and artificial tears after two weeks, which were not similar to findings from the other trials. Based on all other objective clinical assessments included in this review, AS was not associated with improvements in aqueous tear production measured by Schirmer's test (two trials, 33 participants), ocular surface condition with fluorescein (four trials, 72 participants) or Rose Bengal staining (three trials, 60 participants), and epithelial metaplasia by impression cytology compared to artificial tears (one trial, 12 participants). Data on adverse effects were not reported by three of the included studies. In one study, there were no serious adverse events reported with the collection of and treatment with AS.Overall there was inconsistency in the possible benefits of AS in improving participant-reported symptoms and TBUT and lack of effect based on other objective clinical measures. Well-planned, large, high-quality RCTs are warranted, in different severities of dry eye and using standardized questionnaires to measure participant-reported outcomes and objective clinical tests as well as objective biomarkers to assess the benefit of AS therapy for dry eye." @default.
• W1532055560 created "2016-06-24" @default.
• W1532055560 creator A5046778519 @default.
• W1532055560 creator A5066549215 @default.
• W1532055560 creator A5066770174 @default.
• W1532055560 creator A5067112714 @default.
• W1532055560 creator A5089711357 @default.
• W1532055560 date "2013-08-27" @default.
• W1532055560 modified "2023-09-30" @default.
• W1532055560 title "Autologous serum eye drops for dry eye." @default.
• W1532055560 cites W145780728 @default.
• W1532055560 cites W1523354060 @default.
• W1532055560 cites W1530639720 @default.
• W1532055560 cites W1532055560 @default.
• W1532055560 cites W153517635 @default.
• W1532055560 cites W1535475051 @default.
• W1532055560 cites W1595675376 @default.
• W1532055560 cites W1902102829 @default.
• W1532055560 cites W1966632162 @default.
• W1532055560 cites W1967272259 @default.
• W1532055560 cites W1967795477 @default.
• W1532055560 cites W1969353985 @default.
• W1532055560 cites W1973180551 @default.
• W1532055560 cites W1973315061 @default.
• W1532055560 cites W1978568512 @default.
• W1532055560 cites W1982767852 @default.
• W1532055560 cites W1983572883 @default.
• W1532055560 cites W1985128016 @default.
• W1532055560 cites W198540002 @default.
• W1532055560 cites W1988865180 @default.
• W1532055560 cites W1988967364 @default.
• W1532055560 cites W1992873140 @default.
• W1532055560 cites W1993624680 @default.
• W1532055560 cites W1995697344 @default.
• W1532055560 cites W1997357305 @default.
• W1532055560 cites W1998005154 @default.
• W1532055560 cites W2001968948 @default.
• W1532055560 cites W2002006975 @default.
• W1532055560 cites W2008878337 @default.
• W1532055560 cites W2012582550 @default.
• W1532055560 cites W2013281526 @default.
• W1532055560 cites W2020754761 @default.
• W1532055560 cites W2023837187 @default.
• W1532055560 cites W2023854118 @default.
• W1532055560 cites W2024484902 @default.
• W1532055560 cites W2026755621 @default.
• W1532055560 cites W2027735186 @default.
• W1532055560 cites W2028465131 @default.
• W1532055560 cites W2029285814 @default.
• W1532055560 cites W2030826031 @default.
• W1532055560 cites W2033568594 @default.
• W1532055560 cites W2036649302 @default.
• W1532055560 cites W2037239844 @default.
• W1532055560 cites W2037817461 @default.
• W1532055560 cites W2042799196 @default.
• W1532055560 cites W2045851727 @default.
• W1532055560 cites W2046591915 @default.
• W1532055560 cites W2048741183 @default.
• W1532055560 cites W2050235928 @default.
• W1532055560 cites W2050313449 @default.
• W1532055560 cites W2055370551 @default.
• W1532055560 cites W2055487699 @default.
• W1532055560 cites W2062202268 @default.
• W1532055560 cites W2063642231 @default.
• W1532055560 cites W2064893789 @default.
• W1532055560 cites W2068119665 @default.
• W1532055560 cites W2068388876 @default.
• W1532055560 cites W2070412262 @default.
• W1532055560 cites W2071244844 @default.
• W1532055560 cites W2071783840 @default.
• W1532055560 cites W2072021875 @default.
• W1532055560 cites W2075627451 @default.
• W1532055560 cites W2078501398 @default.
• W1532055560 cites W2079220477 @default.
• W1532055560 cites W2081205285 @default.
• W1532055560 cites W2081349360 @default.
• W1532055560 cites W2083507337 @default.
• W1532055560 cites W2088344821 @default.
• W1532055560 cites W2093220756 @default.
• W1532055560 cites W2093520231 @default.
• W1532055560 cites W2094818657 @default.
• W1532055560 cites W2095820867 @default.
• W1532055560 cites W2098165348 @default.
• W1532055560 cites W2102245343 @default.
• W1532055560 cites W2115345791 @default.
• W1532055560 cites W2125257449 @default.
• W1532055560 cites W2125435699 @default.
• W1532055560 cites W2129071366 @default.
• W1532055560 cites W2129493880 @default.
• W1532055560 cites W2133216703 @default.
• W1532055560 cites W2134048257 @default.
• W1532055560 cites W2147254926 @default.
• W1532055560 cites W2147891251 @default.
• W1532055560 cites W2150000837 @default.
• W1532055560 cites W2150621857 @default.
• W1532055560 cites W2152079580 @default.
• W1532055560 cites W2155730691 @default.
• W1532055560 cites W2156030957 @default.
• W1532055560 cites W2158537973 @default.
• W1532055560 cites W2160107844 @default.

• next